Replimune Group, Inc.
USD8.87
-0.13 (-1.44%)
CEO
Sushil Patel
IPO Date
2018-07-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$8.90
Prev. Close
$9.00
Day Low
$8.53
Day High
$9.49
52W Low
$1.50
52W High
$13.24
Market Cap
$0.73B
Volume
6.20M
| 7,894 |
| $5.08 |
| 20 May 2026 | Sarchi Christopher | Chief Commercial Officer | S-Sale | Disposed | 8,626 | $5.08 |
| 20 May 2026 | Astley-Sparke Philip | director | S-Sale | Disposed | 17,657 | $5.08 |
| 20 May 2026 | Patel Sushil | director, officer: Chief Executive Officer | S-Sale | Disposed | 37,324 | $5.08 |
| 20 May 2026 | Hill Emily Luisa | Chief Financial Officer | S-Sale | Disposed | 7,812 | $5.08 |
| 7 Apr 2026 | BAKER BROS. ADVISORS LP | director, 10 percent owner: | A-Award | Acquired | 44,500 | $7.61 |
| 7 Apr 2026 | Sarchi Christopher | Chief Commercial Officer | A-Award | Acquired | 50,000 | $0.00 |
| 7 Apr 2026 | Sarchi Christopher | Chief Commercial Officer | A-Award | Acquired | 75,000 | $7.61 |
| 7 Apr 2026 | Astley-Sparke Philip | director | A-Award | Acquired | 50,000 | $0.00 |